Key data
| Regulation | Commission Implementing Decision (EU) 2026/2564, of 19 November 2026 |
|---|---|
| Publication | 20 November 2026 |
| Entry into force | 19 November 2026 |
| Affected parties | Manufacturers, distributors and professional applicators of biocides with hydrogen cyanide (HCN) |
| Category | European Regulation |
| Legal basis | Regulation (EU) No 528/2012 of the European Parliament and of the Council |
| Types of products affected | Type 8 (wood protection), Type 14 (rodenticides), Type 18 (insecticides, acaricides and products for controlling other arthropods) |
Companies in the pest control, fumigation and wood treatment sector that work with hydrogen cyanide (HCN) have a guaranteed window of operational continuity. Implementing Decision (EU) 2026/2564, published on 20 November 2026 and in force since 19 November, delays the expiration date of HCN approval as a biocidal active substance, preventing operators from being left in a legal vacuum while the European Commission completes its evaluation process.
The measure is based on Regulation (EU) No 528/2012, which regulates the marketing and use of biocides in the European Union. This is not a renewed definitive approval, but rather a technical extension to prevent the authorization from expiring before the ongoing scientific evaluation is concluded.
What does this regulation establish?
The Decision delays the expiration date of the approval of hydrogen cyanide (HCN) for use in three specific types of biocidal products:
| Product type | Category | Main applications |
|---|---|---|
| Type 8 | Wood protection | Treatment of wood against destructive organisms |
| Type 14 | Rodenticides | Rodent control |
| Type 18 | Insecticides, acaricides and products for controlling other arthropods | Fumigation and control of insects and mites |
The justification for the extension is exclusively procedural: the evaluation process of the active substance has not been completed and, without this decision, the authorization would have expired leaving operators without regulatory coverage. The extension guarantees the continuity of the current legal framework until a definitive resolution is issued.
It is essential to understand that this decision does not modify the conditions of use of HCN nor does it expand its authorized applications. It simply extends the period during which the existing approval remains valid.
Economic and operational impact
For affected companies, the immediate impact is positive: there is no interruption of activity. Without this extension, operators working with HCN would have had to stop the marketing and application of these products when the authorization expired, with the consequent operational cost and cost of substituting active substances.
However, the extension has an uncertain time horizon, which generates a relevant planning risk:
- The definitive evaluation may conclude with the renewal of approval, allowing continuation with HCN under possibly updated conditions.
- It may also conclude with non-renewal, which would require seeking alternative active substances, reformulating products and obtaining new authorizations, processes that can take years and involve significant investments.
- Companies that do not monitor the progress of the evaluation may be surprised by tight adaptation deadlines.
The cost of not acting now is greater than the cost of preparing: identifying alternatives to HCN and evaluating their technical and economic feasibility is a planning investment that can prevent a future operational crisis.
Who does it affect?
- Biocide manufacturers that include hydrogen cyanide (HCN) in their formulations for product types 8, 14 and 18.
- Distributors and marketers of biocidal products with HCN in the European market.
- Professional applicators in the pest control sector that use HCN in fumigations.
- Wood treatment companies that use HCN as a type 8 biocide for protection against wood-destroying organisms.
- Fumigation operators in industrial, agricultural facilities, warehouses and means of transport.
- Regulatory advisors and compliance officers of companies in the chemical and pest control sector.
Practical example
A pest control company operating in Spain that uses fumigation products with HCN (product type 18) for the treatment of grain warehouses and means of transport was facing the possible expiration of the authorization of the active substance. Without Decision 2026/2564, it would have had to interrupt the use of these products when HCN approval expired, urgently seek approved alternatives and renegotiate contracts with clients.
Thanks to the extension, this company can continue operating normally under the current regulatory framework. However, its technical director should already begin an analysis of alternative active substances for product types 8, 14 and 18, so that if the definitive evaluation concludes with non-renewal of HCN, the company has a transition plan ready and does not depend on emergency adaptation deadlines.
What should companies do now?
- Verify if your products are affected: Check if the biocides you manufacture, distribute or apply contain HCN and if they are classified in product types 8, 14 or 18.
- Document the extension in the regulatory file: Update internal compliance records with the reference to Implementing Decision (EU) 2026/2564 and its entry into force date (19 November 2026).
- Monitor the progress of HCN evaluation: Follow the publications of the European Chemicals Agency (ECHA) to learn about the status and expected timelines of the definitive evaluation.
- Initiate an analysis of alternatives: Identify alternative active substances to HCN for each affected product type and evaluate their technical, economic and regulatory feasibility.
- Plan a non-renewal scenario: Develop a contingency plan that includes reformulation timelines, estimated substitution costs and new authorization requirements, so you do not act under pressure if the evaluation concludes negatively.
- Consult with regulatory advisors specialized in biocides: Managing active substances under Regulation (EU) 528/2012 requires specific technical knowledge; a specialized advisor can anticipate the necessary steps and reduce risks.
Frequently asked questions
Can I continue using biocidal products with hydrogen cyanide after this decision?
Yes. Implementing Decision (EU) 2026/2564 extends the expiration date of HCN approval for product types 8, 14 and 18. Manufacturers, distributors and professional applicators can continue operating under the current regulatory framework during the extension period, without the need for immediate changes.
What types of biocidal products are affected by the HCN extension?
The extension covers three product types: type 8 (wood protection), type 14 (rodenticides) and type 18 (insecticides, acaricides and products for controlling other arthropods). If your company works with HCN in any of these uses, the extension applies directly to you.
When will it be known if HCN maintains its definitive authorization as a biocide?
The Decision does not set a specific date for the definitive resolution. The extension exists precisely because the evaluation process of the active substance has not been completed. To learn about the updated status, you must consult ECHA publications and the EU Official Journal. It is recommended to monitor these sources periodically.
What happens if the definitive evaluation concludes with non-renewal of HCN?
If the European Commission decides not to renew HCN approval, companies will have to stop marketing and applying biocidal products with this active substance in the affected product types. This would involve seeking alternative substances, reformulating products and obtaining new authorizations, a process that can be long and costly. This is why it is recommended to start analyzing alternatives now.
What legal basis regulates this extension and where can I consult it?
The extension is based on Regulation (EU) No 528/2012 of the European Parliament and of the Council, which regulates the marketing and use of biocides in the EU. The specific decision is Implementing Decision (EU) 2026/2564, published on 20 November 2026 in the EU Official Journal. You can consult it in the official source linked at the end of this article.
Official source
Consult complete regulation in official source
Disclaimer: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://eur-lex.europa.eu/./legal-content/AUTO/?uri=OJ:L_202602564